Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer.
Yaping HuangChengjie KeJiaqin CaiXiaoxia WeiMaohua ChenHong SunPublished in: Breast cancer (Tokyo, Japan) (2024)
Our study will offer valuable guidance for physicians or patients when making treatment decisions and provide an effective reference for decision-making to consider the appropriate allocation of funds to this special group.